Research programme: stem cell therapeutics - NextCell Pharma
Latest Information Update: 17 Mar 2017
At a glance
- Originator NextCell Pharma
- Class Cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Renal transplant rejection; Type 1 diabetes mellitus
Most Recent Events
- 09 Mar 2017 Early research in Renal transplant rejection in Sweden (unspecified route)
- 09 Mar 2017 Early research in Type-1 diabetes mellitus in Sweden (unspecified route)